Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks

About this update from Restart Life Sciences Corp.

Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide a strategic operational update regarding its collaboration with the Richardson Centre for Food Technology and Research (RCFTR) at the University of Manitoba. Following the recent unveiling of its newly formulated product roadmap, targeted to capitalize on emerging consumer shopping patterns, the Company has successfully integrated the results from its collaboration with the RCFTR into its upcoming formulations. These specialized formulations have officially progressed past the conceptual phase and into the pre-production phase, with finalization processes currently underway to transition into commercial production. A primary directive of this university collaboration involves the commercial development of upcoming SKUs under the Company's wholly owned subsidiary, Holy Crap Foods Inc. The RCFTR food science team has successfully completed work on the core protein line, which has now officially advanced to the pre-production phase. Building on this milestone, development is actively underway for the Company's next two high-growth functional food verticals: the premium youth/kids breakfast sector and the specialized geriatric/seniors nutrition segment. Key Operational Highlights: "Translating top-tier research feedback into scalable, commercial products is central to our operational strategy," said Steve Loutskou, Chief Executive Officer of Restart Life Sciences. "Our work with the food sciences department at the University of Manitoba has allowed us to integrate science-backed knowledge into our new SKU framework. Moving these initiatives into the pre-production phase brings us one step closer to launching our specialized SKUs. We are finalizing our production frameworks now and look forward to introducing these products to the market shortly."

View stock analysis, news, and events for Restart Life Sciences Corp.